Inflammation  >>  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
PAW01, NCT00829257 / 2008-001811-40: Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma

Completed
4
15
Europe
HFA-BDP, Fluticasone, Seretide
University of Dundee
Asthma
07/10
07/10
NCT00921921 / 2008-005909-19: Does Extra-fine Hydrofluoroalkane-beclomethasone Dipropionate (HFA-BDP) Suppress Small Airways Inflammation in Chronic Obstructive Pulmonary Disease (COPD)?

Completed
4
16
Europe
HFA-BDP, Qvar, Placebo
University of Dundee
COPD
10/11
10/11
2005-001997-29: A Proof of Concept Study into the Effects on Inhlaed Extra-Fine and Standard Formulations of Beclomethasone Dipropionate and Oral Montelukast on Surrogate Markers of Small and Large Airway Inflammation in Asthma

Ongoing
4
30
Europe
Beclazone, QVAR, Singulair, Beclazone, QVAR, Singulair
University of Dundee
Asthma
 
 

Download Options